Zealand Pharma says obesity drug deal with Roche will help it stay independent
Danish biotech is developing petrelintide in partnership with the Swiss pharma group
Full Article
Zealand Pharma says obesity drug deal with Roche will help it stay independent
FT.com
0 shares
1 views
You might like
Related news coverage
Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit
The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish biotech..
Upworthy